-
1
-
-
34548396844
-
Depression, chronic diseases, and decrements in health: Results from the World Health Surveys
-
DOI 10.1016/S0140-6736(07)61415-9, PII S0140673607614159
-
Moussavi S, Chatterji E, Verdes A, Tandon A, Patel V, Ustun B. Depression, chronic disease and decrements in health: results from WHO surveys. Lancet 2007;370:851-8. (Pubitemid 47362344)
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 851-858
-
-
Moussavi, S.1
Chatterji, S.2
Verdes, E.3
Tandon, A.4
Patel, V.5
Ustun, B.6
-
2
-
-
20344374645
-
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
-
DOI 10.1001/archpsyc.62.6.617
-
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27. (Pubitemid 40973437)
-
(2005)
Archives of General Psychiatry
, vol.62
, Issue.6
, pp. 617-627
-
-
Kessler, R.C.1
Wai, T.C.2
Demler, O.3
Walters, E.E.4
-
3
-
-
20344385026
-
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication
-
Kessler RC, Berglund P, Delmer O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:590-2.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 590-592
-
-
Kessler, R.C.1
Berglund, P.2
Delmer, O.3
Jin, R.4
Merikangas, K.R.5
Walters, E.E.6
-
4
-
-
0030987364
-
Major depression and all-cause mortality among white adults in the United States
-
DOI 10.1016/S1047-2797(97)00014-8, PII S1047279797000148
-
Zheng D, Macera CA, Croft JB, Giles WH, Davis D, Scott WK. Major depression and all-cause mortality among white adults in the United States. Ann Epidemiol 1997;7:213-8. (Pubitemid 27203923)
-
(1997)
Annals of Epidemiology
, vol.7
, Issue.3
, pp. 213-218
-
-
Zheng, D.1
Macera, C.A.2
Croft, J.B.3
Giles, W.H.4
Davis, D.5
Scott, W.K.6
-
5
-
-
0036890097
-
Excess mortality in depression: A meta-analysis of community studies
-
DOI 10.1016/S0165-0327(01)00413-X, PII S016503270100413X
-
Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002;72:227-36. (Pubitemid 35351282)
-
(2002)
Journal of Affective Disorders
, vol.72
, Issue.3
, pp. 227-236
-
-
Cuijpers, P.1
Smit, F.2
-
7
-
-
0141497911
-
Depression in cancer: New developments regarding diagnosis and treatment
-
DOI 10.1016/S0006-3223(03)00413-X
-
Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003;54:283-94. (Pubitemid 37267858)
-
(2003)
Biological Psychiatry
, vol.54
, Issue.3
, pp. 283-294
-
-
Raison, C.L.1
Miller, A.H.2
-
8
-
-
34250168345
-
Depression and ischemic heart disease: What have we learned from clinical trials?
-
DOI 10.1097/HCO.0b013e3281ead011, PII 0000157320070700000005
-
Rivelli S, Jiang W. Depression and ischemic heart disease: What have we learned from clinical trials? Curr Opin Cardiol 2007;22:286-91. (Pubitemid 46900753)
-
(2007)
Current Opinion in Cardiology
, vol.22
, Issue.4
, pp. 286-291
-
-
Rivelli, S.1
Jiang, W.2
-
9
-
-
36749099046
-
Medical co-morbidity in depressive disorders
-
DOI 10.1080/10401230701653542, PII 787700371
-
Benton T, Staab J, Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry 2007;19:289-303. (Pubitemid 350208802)
-
(2007)
Annals of Clinical Psychiatry
, vol.19
, Issue.4
, pp. 289-303
-
-
Benton, T.1
Staab, J.2
Evans, D.L.3
-
10
-
-
85047696637
-
STAR*D: What have we learned?
-
Rush AJ. STAR*D: What have we learned? Am J Psychiatry 2007;164:201-4.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 201-204
-
-
Rush, A.J.1
-
11
-
-
63449122724
-
Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression
-
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 732-741
-
-
Miller, A.H.1
Maletic, V.2
Raison, C.L.3
-
12
-
-
30544445602
-
Cytokines sing the blues: Inflammation and the pathogenesis of depression
-
DOI 10.1016/j.it.2005.11.006, PII S1471490605002887
-
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
-
(2006)
Trends in Immunology
, vol.27
, Issue.1
, pp. 24-31
-
-
Raison, C.L.1
Capuron, L.2
Miller, A.H.3
-
13
-
-
77958068373
-
The concept of depression as a dysfunction of the immune system
-
Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010;6:205-12.
-
(2010)
Curr Immunol Rev
, vol.6
, pp. 205-212
-
-
Leonard, B.E.1
-
14
-
-
58349113599
-
Activation of central nervous system inflammatory pathways by interferon-alpha: Relationship to monoamines and depression
-
Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009;65:296-303.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 296-303
-
-
Raison, C.L.1
Borisov, A.S.2
Majer, M.3
Drake, D.F.4
Pagnoni, G.5
Woolwine, B.J.6
-
15
-
-
7244257593
-
A novel action of minocycline: Inhibition of human immunodeficiency virus type 1 infection in microglia
-
DOI 10.1080/13550280490499533
-
Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, Goldstein H, et al. A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 2004;10:284-92. (Pubitemid 39429939)
-
(2004)
Journal of NeuroVirology
, vol.10
, Issue.5
, pp. 284-292
-
-
Si, Q.1
Cosenza, M.A.2
Kim, M.-O.3
Zhao, M.-L.4
Brownlee, M.5
Goldstein, H.6
Lee, S.C.7
-
16
-
-
42449095441
-
Neurotransmitters, peptides and cytokines process in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorder
-
Anisman H, Merali Z, Hayley S. Neurotransmitters, peptides and cytokines process in relation to depressive disorder: comorbidity between depression and neurodegenerative disorder. Prog Neurobiol Biol Psychiat 2008;85:1-74.
-
(2008)
Prog Neurobiol Biol Psychiat
, vol.85
, pp. 1-74
-
-
Anisman, H.1
Merali, Z.2
Hayley, S.3
-
17
-
-
65649152524
-
Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis
-
Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86.
-
(2009)
Psychosom Med
, vol.71
, pp. 171-186
-
-
Howren, M.B.1
Lamkin, D.M.2
Suls, J.3
-
18
-
-
0347604853
-
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
-
DOI 10.1007/s00213-003-1566-z
-
Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003;170:429-33. (Pubitemid 38010515)
-
(2003)
Psychopharmacology
, vol.170
, Issue.4
, pp. 429-433
-
-
Tuglu, C.1
Kara, S.H.2
Caliyurt, O.3
Vardar, E.4
Abay, E.5
-
19
-
-
0346914336
-
Raised Plasma Levels of Tumor Necrosis Factor alpha in Patients with Depression: Normalization during Electroconvulsive Therapy
-
DOI 10.1097/00124509-200312000-00002
-
Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003;19:183-8. (Pubitemid 38018294)
-
(2003)
Journal of ECT
, vol.19
, Issue.4
, pp. 183-188
-
-
Hestad, K.A.1
Tonseth, S.2
Stoen, C.D.3
Ueland, T.4
Aukrust, P.5
-
20
-
-
0035130217
-
Raised levels of plasma interleukin-1 beta in major and postviral depression
-
DOI 10.1034/j.1600-0447.2001.00162.x
-
Owen BM, Eccleston D, Ferrier IN, Young AH. Raised levels of plasma interleukin-1-beta in major and postviral depression. Acta Psychiatr Scand 2001;103:226-8. (Pubitemid 32154355)
-
(2001)
Acta Psychiatrica Scandinavica
, vol.103
, Issue.3
, pp. 226-228
-
-
Owen, B.M.1
Eccleston, D.2
Ferrier, I.N.3
Young, H.4
-
21
-
-
11844275924
-
Increase in interleukin-1-beta in late-life depression
-
Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1-beta in late-life depression. Am J Psychiatry 2005;162:175-7.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 175-177
-
-
Thomas, A.J.1
Davis, S.2
Morris, C.3
Jackson, E.4
Harrison, R.5
O'Brien, J.T.6
-
22
-
-
0042844775
-
Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response
-
Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003;28:1182-5.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 1182-1185
-
-
Yu, Y.W.1
Chen, T.J.2
Hong, C.J.3
Chen, H.M.4
Tsai, S.J.5
-
23
-
-
0041832184
-
Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population
-
Jun TY, Pae CU, Hoon-Han, Chae JH, Bahk WM, Kim KS, et al. Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 2003;13:179-81.
-
(2003)
Psychiatr Genet
, vol.13
, pp. 179-181
-
-
Jun, T.Y.1
Pae, C.U.2
Hoon-Han3
Chae, J.H.4
Bahk, W.M.5
Kim, K.S.6
-
24
-
-
34248529643
-
Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age
-
DOI 10.1016/j.exger.2007.01.011, PII S0531556507000290
-
van den Biggelaar AH, Gussekloo J, de Craen AJ, Frölich M, Stek ML, van der Mast RC, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 2007;42:693-701. (Pubitemid 46756098)
-
(2007)
Experimental Gerontology
, vol.42
, Issue.7
, pp. 693-701
-
-
Van Den, B.A.H.J.1
Gussekloo, J.2
De Craen, A.J.M.3
Frolich, M.4
Stek, M.L.5
Van Der Mast, R.C.6
Westendorp, R.G.J.7
-
25
-
-
21044444562
-
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications
-
DOI 10.1210/jc.2004-1667
-
Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90:2522-30. (Pubitemid 40686286)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.5
, pp. 2522-2530
-
-
Alesci, S.1
Martinez, P.E.2
Kelkar, S.3
Ilias, I.4
Ronsaville, D.S.5
Listwak, S.J.6
Ayala, A.R.7
Licinio, J.8
Gold, H.K.9
Kling, M.A.10
Chrousos, G.P.11
Gold, P.W.12
-
26
-
-
0037114792
-
Clinical depression and inflammatory risk markers for coronary heart disease
-
DOI 10.1016/S0002-9149(02)02863-1, PII S0002914902028631
-
Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83. (Pubitemid 35449470)
-
(2002)
American Journal of Cardiology
, vol.90
, Issue.12
, pp. 1279-1283
-
-
Miller, G.E.1
Stetler, C.A.2
Carney, R.M.3
Freedland, K.E.4
Banks, W.A.5
-
27
-
-
0035021538
-
Cytokine-associated emotional and cognitive disturbances in humans
-
Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-52. (Pubitemid 32411324)
-
(2001)
Archives of General Psychiatry
, vol.58
, Issue.5
, pp. 445-452
-
-
Reichenberg, A.1
Yirmiya, R.2
Schuld, A.3
Kraus, T.4
Haack, M.5
Morag, A.6
Pollmacher, T.7
-
28
-
-
43049177729
-
Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans
-
Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008;63:1022-9.
-
(2008)
Biol Psychiatry
, vol.63
, pp. 1022-1029
-
-
Brydon, L.1
Harrison, N.A.2
Walker, C.3
Steptoe, A.4
Critchley, H.D.5
-
29
-
-
0031889797
-
A perspective on the clinical effectiveness and tolerance of interferon- alpha
-
Borden EC, Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol 1998;25:3-8. (Pubitemid 28093149)
-
(1998)
Seminars in Oncology
, vol.25
, Issue.1 SUPPL.
, pp. 3-8
-
-
Borden, E.C.1
Parkinson, D.2
-
30
-
-
36448961244
-
Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory
-
DOI 10.1111/j.1471-4159.2007.04987.x
-
Wu CW, Chen YC, Yu L, Chen HI, Jen CJ, Huang AM, et al. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J Neurochem 2007;103:2471-81. (Pubitemid 350173589)
-
(2007)
Journal of Neurochemistry
, vol.103
, Issue.6
, pp. 2471-2481
-
-
Wu, C.-W.1
Chen, Y.-C.2
Yu, L.3
Chen, H.-I.4
Jen, C.J.5
Huang, A.-M.6
Tsai, H.-J.7
Chang, Y.-T.8
Kuo, Y.-M.9
-
31
-
-
13944257674
-
Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus
-
DOI 10.1523/JNEUROSCI.3741-04.2005
-
Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005;25:1089-94. (Pubitemid 40268949)
-
(2005)
Journal of Neuroscience
, vol.25
, Issue.5
, pp. 1089-1094
-
-
Sairanen, M.1
Lucas, G.2
Ernfors, P.3
Castren, M.4
Castren, E.5
-
32
-
-
58549087919
-
Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface
-
Norman Cousins Lecture
-
Miller AH. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 2009;23:149-58.
-
(2009)
Brain Behav Immun
, vol.23
, pp. 149-158
-
-
Miller, A.H.1
-
33
-
-
35848935025
-
Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression
-
DOI 10.1016/j.biopsych.2007.05.026, PII S0006322307005227, Depression: New Perspectives on Treatment and Etiology
-
Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM, et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 2007;62:1324-33. (Pubitemid 350060899)
-
(2007)
Biological Psychiatry
, vol.62
, Issue.11
, pp. 1324-1333
-
-
Felger, J.C.1
Alagbe, O.2
Hu, F.3
Mook, D.4
Freeman, A.A.5
Sanchez, M.M.6
Kalin, N.H.7
Ratti, E.8
Nemeroff, C.B.9
Miller, A.H.10
-
34
-
-
0030043899
-
Immune-neuro-endocrine interactions: Facts and hypotheses
-
DOI 10.1210/er.17.1.64
-
Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996;17:64-102. (Pubitemid 26061368)
-
(1996)
Endocrine Reviews
, vol.17
, Issue.1
, pp. 64-102
-
-
Besedovsky, H.O.1
Del, R.A.2
-
35
-
-
0035280252
-
Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment
-
DOI 10.1016/S0006-3223(00)01088-X, PII S000632230001088X
-
Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391-404. (Pubitemid 32234301)
-
(2001)
Biological Psychiatry
, vol.49
, Issue.5
, pp. 391-404
-
-
Pariante, C.M.1
Miller, A.H.2
-
36
-
-
38449088518
-
Type 1 interferon in systemic lupus erythematosus
-
Crow MK. Type 1 interferon in systemic lupus erythematosus. Curr Top Microbiol Immunol 2007;316:359-86.
-
(2007)
Curr Top Microbiol Immunol
, vol.316
, pp. 359-386
-
-
Crow, M.K.1
-
37
-
-
0036199336
-
Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions
-
DOI 10.1016/S0893-133X(01)00407-9, PII S0893133X01004079
-
Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643-52. (Pubitemid 34260983)
-
(2002)
Neuropsychopharmacology
, vol.26
, Issue.5
, pp. 643-652
-
-
Capuron, L.1
Gumnick, J.F.2
Musselman, D.L.3
Lawson, D.H.4
Reemsnyder, A.5
Nemeroff, C.B.6
Miller, A.H.7
-
38
-
-
0031913835
-
Mood and cognitive side effects of interferon-alpha therapy
-
Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998;25:39-47. (Pubitemid 28093154)
-
(1998)
Seminars in Oncology
, vol.25
, Issue.1 SUPPL.
, pp. 39-47
-
-
Valentine, A.D.1
Meyers, C.A.2
Kling, M.A.3
Richelson, E.4
Hauser, P.5
-
40
-
-
0028003787
-
Suicide associated with alfa-interferon therapy for chronic viral hepatitis
-
Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994;21:241-3. (Pubitemid 24270552)
-
(1994)
Journal of Hepatology
, vol.21
, Issue.2
, pp. 241-243
-
-
Janssen, H.L.A.1
Brouwer, J.T.2
Van Der, M.R.C.3
Schalm, S.W.4
-
41
-
-
14644393659
-
Neuropsychiatric adverse effects of interferon-alpha: Recognition and management
-
DOI 10.2165/00023210-200519020-00002
-
Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005;19:105-23. (Pubitemid 40321763)
-
(2005)
CNS Drugs
, vol.19
, Issue.2
, pp. 105-123
-
-
Raison, C.L.1
Demetrashvili, M.2
Capuron, L.3
Miller, A.H.4
-
42
-
-
0035967235
-
Paroxetine for the prevention of depression induced by high-dose interferon alfa
-
DOI 10.1056/NEJM200103293441303
-
Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-6. (Pubitemid 32240314)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.13
, pp. 961-966
-
-
Musselman, D.L.1
Lawson, D.H.2
Gumnick, J.F.3
Manatunga, A.K.4
Penna, S.5
Goodkin, R.S.6
Greiner, K.7
Nemeroff, C.B.8
Miller, A.H.9
-
43
-
-
34447628313
-
Depression following pegylated interferon-alpha: Characteristics and vulnerability
-
DOI 10.1016/j.jpsychores.2007.05.013, PII S0022399907002164
-
Lotrich FE, Rabinovitz M, Gironda P, Pollock BG. Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res 2007;63:131-5. (Pubitemid 47088561)
-
(2007)
Journal of Psychosomatic Research
, vol.63
, Issue.2
, pp. 131-135
-
-
Lotrich, F.E.1
Rabinovitz, M.2
Gironda, P.3
Pollock, B.G.4
-
44
-
-
0035894157
-
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms
-
DOI 10.1016/S0165-1781(01)00315-8, PII S0165178101003158
-
Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 2001;105:45-55. (Pubitemid 34015882)
-
(2001)
Psychiatry Research
, vol.105
, Issue.1-2
, pp. 45-55
-
-
Bonaccorso, S.1
Puzella, A.2
Marino, V.3
Pasquini, M.4
Biondi, M.5
Artini, M.6
Almerighi, C.7
Levrero, M.8
Egyed, B.9
Bosmans, E.10
Meltzer, H.Y.11
Maes, M.12
-
45
-
-
33846491758
-
Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol
-
DOI 10.1016/j.jpsychores.2006.09.007, PII S0022399906004296
-
Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res 2007;62:207-14. (Pubitemid 46161588)
-
(2007)
Journal of Psychosomatic Research
, vol.62
, Issue.2
, pp. 207-214
-
-
Wichers, M.C.1
Kenis, G.2
Koek, G.H.3
Robaeys, G.4
Nicolson, N.A.5
Maes, M.6
-
46
-
-
72649100666
-
Cytokine-induced depression during IFN-alpha treatment: The role of IL-6 and sleep quality
-
Prather AA, Rabinovitz M, Pollock BG, Lotrich FE. Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun 2009;23:1109-16.
-
(2009)
Brain Behav Immun
, vol.23
, pp. 1109-1116
-
-
Prather, A.A.1
Rabinovitz, M.2
Pollock, B.G.3
Lotrich, F.E.4
-
47
-
-
4644232945
-
Meta-analysis of serotonin transporter polymorphisms and affective disorders
-
DOI 10.1097/00041444-200409000-00001
-
Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet 2004;14:121-9. (Pubitemid 39281818)
-
(2004)
Psychiatric Genetics
, vol.14
, Issue.3
, pp. 121-129
-
-
Lotrich, F.E.1
Pollock, B.G.2
-
48
-
-
19944433505
-
The power of sample size and homogenous sampling: Association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder
-
DOI 10.1016/j.biopsych.2004.11.027, PII S0006322304012296
-
Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Höfels S, Gross M, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005;57:247-51. (Pubitemid 40187368)
-
(2005)
Biological Psychiatry
, vol.57
, Issue.3
, pp. 247-251
-
-
Hoefgen, B.1
Schulze, T.G.2
Ohlraun, S.3
Von Widdern, O.4
Hofels, S.5
Gross, M.6
Heidmann, V.7
Kovalenko, S.8
Eckermann, A.9
Kolsch, H.10
Metten, M.11
Zobel, A.12
Becker, T.13
Nothen, M.M.14
Propping, P.15
Heun, R.16
Maier, W.17
Rietschel, M.18
-
49
-
-
58349101061
-
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism
-
Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 2009;65:344-8.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 344-348
-
-
Lotrich, F.E.1
Ferrell, R.E.2
Rabinovitz, M.3
Pollock, B.G.4
-
50
-
-
34548508884
-
Preventing relapse of major depression during interferon-alpha therapy for hepatitis C - A pilot study
-
DOI 10.1007/s10620-006-9729-5
-
Gleason OC, Fucci JC, Yates WR, Philipsen MA. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C - a pilot study. Dig Dis Sci 2007;52:2557-63. (Pubitemid 47373913)
-
(2007)
Digestive Diseases and Sciences
, vol.52
, Issue.10
, pp. 2557-2563
-
-
Gleason, O.C.1
Fucci, J.C.2
Yates, W.R.3
Philipsen, M.A.4
-
51
-
-
13244249842
-
Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression
-
DOI 10.1111/j.1365-2893.2005.00554.x
-
Kraus MR, Shafer A, Al-Taie O, Scheurlen M. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepatitis 2005;12:96-100. (Pubitemid 40188781)
-
(2005)
Journal of Viral Hepatitis
, vol.12
, Issue.1
, pp. 96-100
-
-
Kraus, M.R.1
Schafer, A.2
Al-Taie, O.3
Scheurlen, M.4
-
52
-
-
18844395344
-
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C
-
DOI 10.1016/j.jhep.2005.01.020, PII S0168827805001807
-
Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, et al. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol 2005;42:793-8. (Pubitemid 40693194)
-
(2005)
Journal of Hepatology
, vol.42
, Issue.6
, pp. 793-798
-
-
Schaefer, M.1
Schwaiger, M.2
Garkisch, A.S.3
Pich, M.4
Hinzpeter, A.5
Uebelhack, R.6
Heinz, A.7
Van Boemmel, F.8
Berg, T.9
-
53
-
-
34247504755
-
A randomized trial of paroxetine to prevent interferon-a-induced depression in patients with hepatitis C
-
Morasco BJ, Rifai MA, Loftis JM, Indest DW, Moles JK, Hauser P. A randomized trial of paroxetine to prevent interferon-a-induced depression in patients with hepatitis C. J Affect Dis 2007;103:83-90.
-
(2007)
J Affect Dis
, vol.103
, pp. 83-90
-
-
Morasco, B.J.1
Rifai, M.A.2
Loftis, J.M.3
Indest, D.W.4
Moles, J.K.5
Hauser, P.6
-
54
-
-
34247550405
-
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
-
DOI 10.1111/j.1365-2036.2007.03316.x
-
Raison CL, Woolwine BJ, Demetrashvili ZM, Borisov AS, Weinreib R, Staab JP, et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 2007;25:1163-74. (Pubitemid 46650303)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.25
, Issue.10
, pp. 1163-1174
-
-
Raison, C.L.1
Woolwine, B.J.2
Demetrashvili, M.F.3
Borisov, A.S.4
Weinreib, R.5
Staab, J.P.6
Zajecka, J.M.7
Bruno, C.J.8
Henderson, M.A.9
Reinus, J.F.10
Evans, D.L.11
Asnis, G.M.12
Miller, A.H.13
-
55
-
-
66149086109
-
Reactivation of inflammatory bowel disease in a mouse model of depression
-
Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009;136:2280-8.
-
(2009)
Gastroenterology
, vol.136
, pp. 2280-2288
-
-
Ghia, J.E.1
Blennerhassett, P.2
Deng, Y.3
Verdu, E.F.4
Khan, W.I.5
Collins, S.M.6
-
56
-
-
34248665273
-
Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life
-
DOI 10.1176/appi.psy.48.3.223
-
Dan AA, Crone C, Wise TN, Martin LM, Ramsey L, Magee S, et al. Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life. Psychosomatics 2007;48:223-9. (Pubitemid 46769627)
-
(2007)
Psychosomatics
, vol.48
, Issue.3
, pp. 223-229
-
-
Dan, A.A.1
Crone, C.2
Wise, T.N.3
Martin, L.M.4
Ramsey, L.5
Magee, S.6
Sjogren, R.7
Ong, J.P.8
Younossi, Z.M.9
-
57
-
-
37549033110
-
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients
-
Préau M, Marcellin F, Spire B, Ravaux I, Dellamonica P, Blanc D, et al. Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients. J Clin Gastroenterol 2008;42:92-6.
-
(2008)
J Clin Gastroenterol
, vol.42
, pp. 92-96
-
-
Préau, M.1
Marcellin, F.2
Spire, B.3
Ravaux, I.4
Dellamonica, P.5
Blanc, D.6
-
58
-
-
77955161294
-
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha
-
Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol 2010;33:191-7.
-
(2010)
Clin Neuropharmacol
, vol.33
, pp. 191-197
-
-
Lotrich, F.E.1
Ferrell, R.E.2
Rabinovitz, M.3
Pollock, B.G.4
-
59
-
-
79960028292
-
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy
-
Dec 6 [Epub ahead of print]
-
Lotrich FE, Loftis JM, Ferrell RE, Rabinovitz M, Hauser P. IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. J Interferon Cytokine Res 2010 Dec 6 [Epub ahead of print].
-
(2010)
J Interferon Cytokine Res
-
-
Lotrich, F.E.1
Loftis, J.M.2
Ferrell, R.E.3
Rabinovitz, M.4
Hauser, P.5
-
60
-
-
33745617042
-
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
-
DOI 10.1038/sj.mp.4001805, PII 4001805
-
Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006;11:680-4. (Pubitemid 43989814)
-
(2006)
Molecular Psychiatry
, vol.11
, Issue.7
, pp. 680-684
-
-
Muller, N.1
Schwarz, M.J.2
Dehning, S.3
Douhe, A.4
Cerovecki, A.5
Goldstein-Muller, B.6
Spellmann, I.7
Hetzel, G.8
Maino, K.9
Kleindienst, N.10
Moller, H.-J.11
Arolt, V.12
Riedel, M.13
-
61
-
-
0042734767
-
Improved self-control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: Results of PAVIA, an open-label post-marketing survey in Spain
-
Collantes-Esteves E, Fernandez-Perrez C. Improved self-control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Curr Med Res Opin 2003;19:402-10.
-
(2003)
Curr Med Res Opin
, vol.19
, pp. 402-410
-
-
Collantes-Esteves, E.1
Fernandez-Perrez, C.2
-
62
-
-
33646708039
-
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study
-
DOI 10.1097/00004850-200607000-00005, PII 0000485020060700000005
-
Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study. Int Clin Psychopharmacol 2006;21:227-31. (Pubitemid 43740300)
-
(2006)
International Clinical Psychopharmacology
, vol.21
, Issue.4
, pp. 227-231
-
-
Mendlewicz, J.1
Kriwin, P.2
Oswald, P.3
Souery, D.4
Alboni, S.5
Brunello, N.6
-
63
-
-
17644414948
-
Clinical effects of COX-2 inhibitors on cognition in schizophrenia
-
DOI 10.1007/s00406-004-0548-4
-
Müller N, Riedel M, Schwarz MJ, Engel RR. Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005;255:149-51. (Pubitemid 40558607)
-
(2005)
European Archives of Psychiatry and Clinical Neuroscience
, vol.255
, Issue.2
, pp. 149-151
-
-
Muller, N.1
Riedel, M.2
Schwarz, M.J.3
Engel, R.R.4
-
64
-
-
29844440963
-
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial
-
DOI 10.1016/S0140-6736(05)67763-X, PII S014067360567763X
-
Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29-35. (Pubitemid 43038667)
-
(2006)
Lancet
, vol.367
, Issue.9504
, pp. 29-35
-
-
Tyring, S.1
Gottlieb, A.2
Papp, K.3
Gordon, K.4
Leonardi, C.5
Wang, A.6
Lalla, D.7
Woolley, M.8
Jahreis, A.9
Zitnik, R.10
Cella, D.11
Krishnan, R.12
-
65
-
-
37249094173
-
From inflammation to sickness and depression: When the immune system subjugates the brain
-
DOI 10.1038/nrn2297, PII NRN2297
-
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
-
(2008)
Nature Reviews Neuroscience
, vol.9
, Issue.1
, pp. 46-56
-
-
Dantzer, R.1
O'Connor, J.C.2
Freund, G.G.3
Johnson, R.W.4
Kelley, K.W.5
-
66
-
-
33646101010
-
TNF-alpha signaling in depression and anxiety: Behavioral consequences of individual receptor targeting
-
Simen BB, Duman CH, Simen AA, Duman RS. TNF-alpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006;59:775-85.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 775-785
-
-
Simen, B.B.1
Duman, C.H.2
Simen, A.A.3
Duman, R.S.4
|